Sandrena 500microgram gel sachets Regne Unit - anglès - MHRA (Medicines & Healthcare Products Regulatory Agency)

sandrena 500microgram gel sachets

orion pharma (uk) ltd - estradiol hemihydrate - transdermal gel - 500microgram

Methotrexate Orion 2.5 mg tablets Irlanda - anglès - HPRA (Health Products Regulatory Authority)

methotrexate orion 2.5 mg tablets

orion corporation - methotrexate - tablet - 2.5 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate

Methotrexate Orion 10 mg tablets Irlanda - anglès - HPRA (Health Products Regulatory Authority)

methotrexate orion 10 mg tablets

orion corporation - methotrexate - tablet - 10 milligram(s) - folic acid analogues; methotrexate; other immunosuppressants; methotrexate

Simdax Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

simdax

orion pharma (nz) limited - levosimendan 2.5 mg/ml - concentrate for infusion - 2.5 mg/ml - active: levosimendan 2.5 mg/ml excipient: citric acid ethanol povidone - simdax is indicated for the short-term treatment of acutely decompensated chronic heart failure (adhf) in situations where conventional therapy is not sufficient, and in cases where inotropic support is considered appropriate.

Comtan Nova Zelanda - anglès - Medsafe (Medicines Safety Authority)

comtan

orion pharma (nz) limited - entacapone 200mg - film coated tablet - 200 mg - active: entacapone 200mg excipient: croscarmellose sodium ethanol glycerol hydrogenated vegetable oil hypromellose iron oxide red iron oxide yellow magnesium stearate   mannitol microcrystalline cellulose polysorbate 80 purified water sucrose titanium dioxide - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilized on those combinations.